Ausgabe 1/2011
Inhalt (13 Artikel)
Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study
Mikkel Andreassen, Jens Faber, Andreas Kjær, Claus Leth Petersen, Lars Østergaard Kristensen
Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression
Ilan Shimon, Carlos Benbassat, Gloria Tzvetov, Simona Grozinsky-Glasberg
Azathioprine as an alternative treatment in primary hypophysitis
L. Papanastasiou, T. Pappa, V. Tsiavos, E. Tseniklidi, I. Androulakis, G. Kontogeorgos, G. Piaditis
Demographic differences in incidence for pituitary adenoma
Bradley D. McDowell, Robert B. Wallace, Ryan M. Carnahan, Elizabeth A. Chrischilles, Charles F. Lynch, Janet A. Schlechte
Comparison of three methods for the estimation of the pituitary gland volume using magnetic resonance imaging: a stereological study
Tolga Ertekin, Niyazi Acer, Ahmet T. Turgut, Kenan Aycan, Özlem Özçelik, Mehmet Turgut
Prevalence of hematological abnormalities in patients with Sheehan’s syndrome: response to replacement of glucocorticoids and thyroxine
Bashir Ahmad Laway, Shahnaz Ahmad Mir, Mir Iftikhar Bashir, Javid Rasool Bhat, Jeelani Samoon, Abdul Hamid Zargar
Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia
David L. Kleinberg, Pietro Ameri, Baljit Singh
On the shoulders of giants: Harvey Cushing’s experience with acromegaly and gigantism at the Johns Hopkins Hospital, 1896–1912
Courtney Pendleton, Hadie Adams, Roberto Salvatori, Gary Wand, Alfredo Quiñones-Hinojosa
Children with Cushing’s syndrome: primary pigmented nodular adrenocortical disease should always be suspected
Renata Marques Gonçalves da Silva, Emília Pinto, Suzan M. Goldman, Cássio Andreoni, Teresa C. Vieira, Julio Abucham
Effect of dopaminergic drug treatment on surgical findings in prolactinomas
Maria Menucci, Alfredo Quiñones-Hinojosa, Peter Burger, Roberto Salvatori
Is left ventricular dysfunction reversed after treatment of active acromegaly?
Savvas T. H. Toumanidis, Maria Eleftheria Evangelopoulos, Ioannis Ilias, Constantinos Pamboucas, Chrysanthi Trikka, Maria Alevizaki
Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
Troy H. Dillard, S. Humayun Gultekin, Johnny B. Delashaw Jr., Chris G. Yedinak, Edward A. Neuwelt, Maria Fleseriu
Atypical pituitary adenoma with malignant features
Adam N. Mamelak, John D. Carmichael, Patricia Park, Sergei Bannykh, Xuemo Fan, H. Vivien Bonert